Also trades as: 688236.SS (SHH) · $vol 5M
1858.HK HKSE
Beijing Chunlizhengda Medical Instruments Co., Ltd.
1W: -4.0%
1M: -10.1%
3M: -18.2%
YTD: -46.6%
1Y: -55.0%
3Y: -45.0%
5Y: -61.6%
HK$7.48 ($0.95)
-0.35 (-4.53%)
Weekly Expected Move ±5.2%
HK$7
HK$7
HK$7
HK$8
HK$8
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$2M
-100.4% ▼
Capital Expenditures
$49M
-47.9% ▼
5Y CAGR: -18.0%
Free Cash Flow
-$51M
-110.7% ▼
Dividends Paid
$171M
-42.0% ▼
Buybacks
$12M
+0.0% ▲
Net Change in Cash
-$127M
-141.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $283M | $322M | $308M | $278M | $125M |
| Depreciation & Amort. | $15M | $18M | $30M | $35M | $38M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$43M | -$196M | -$296M | $196M | -$74M |
| Other Non-Cash Items | $6M | $20M | -$879K | $3M | -$91M |
| Operating Cash Flow | $261M | $165M | $41M | $512M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$24M | -$199M | -$25M | -$33M | -$49M |
| Acquisitions (Net) | $0 | $0 | $0 | -$7M | -$2M |
| Investment Purchases | $0 | $0 | -$2.2B | -$2.4B | $0 |
| Investment Sales | $0 | $0 | $1.4B | $2.4B | $0 |
| Other Investing | $2M | $9M | $14M | $6K | $107M |
| Investing Cash Flow | -$22M | -$190M | -$763M | -$82M | $56M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$2M | -$2M | -$1M | -$587K |
| Stock Repurchased | $0 | $0 | -$7M | $0 | -$12M |
| Dividends Paid | -$12M | $0 | -$50M | -$120M | -$171M |
| Other Financing | $0 | $1.1B | $0 | $0 | $0 |
| Financing Cash Flow | -$12M | $1.1B | -$59M | -$121M | -$183M |
| Net Change in Cash | $226M | $1.0B | -$779M | $309M | -$127M |
| Cash End of Period | $690M | $1.7B | $957M | $1.3B | $1.1B |
| Free Cash Flow | $237M | -$35M | $16M | $478M | -$51M |